CureSearch for Children's Cancer funds and supportstargeted and innovative children's cancer research with measurableresults, and is the authoritative source of information and resourcesfor all those affected by children's cancer.
(dailyRx News) The goal of personalized therapy is to identify and target a patient’s unique genetic makeup. When it comes to cancer, though, the disease can keep causing new genetic changes. In childhood cancer, this can be particularly challenging.
A new study of the childhood cancer has uncovered very few genetic mutations that can be targeted with personalized therapy. As a result, researchers are now looking at how tumors change in response to treatment.
Neuroblastoma is a rare cancer of the nervous system that occurs almost always in children under the age of 10. It’s diagnosed in about 750 children in the US every year. Most cases appear around the age of 2, and it’s the most common cancer in infants.
Shelby HammondCommunications Manager Email Shelby(240) 235-2205